Stay updated on Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:23:02.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the content is blocked or unavailable rather than showing the study details. This reflects an access restriction rather than a substantive change to the study data.
    Difference
    21%
    Check dated 2026-09-20T01:04:57.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page's metadata. No study details or data were changed.
    Difference
    0.1%
    Check dated 2026-08-29T21:50:48.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5 in the footer. This indicates a small update to the page's version metadata and does not affect the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T23:40:35.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.6.4) replacing the previous (v3.6.3), indicating a background deployment update. No substantive study information or UI content appears to be altered.
    Difference
    0.0%
    Check dated 2026-07-25T17:57:20.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page, signaling a new published update to the study record. The underlying study data remains unchanged.
    Difference
    0.0%
    Check dated 2026-07-04T13:16:29.000Z thumbnail image

Stay in the know with updates to Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.